搜索临床试验以:PD 0200390
总计1183个结果
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en Technologie; Research Foundation Flanders完全的
-
Capital Medical UniversityDuke University; Geneplus-Beijing Co. Ltd.完全的
-
Neuroscience Research AustraliaMichael J. Fox Foundation for Parkinson's Research; Shake it up Australia Foundation; Sensoria...完全的
-
Tongji University招聘中
-
Fondation Ophtalmologique Adolphe de Rothschild完全的
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes of Health...完全的
-
Universidade Estadual Paulista Júlio de Mesquita...Baxter Healthcare Corporation未知
-
Schiffler Cancer CenterUniversity of Washington; Theragenics完全的
-
Second Affiliated Hospital of Soochow University尚未招聘
-
Genzyme, a Sanofi CompanyDiacrin/Genzyme Corporation LLC完全的
-
Second Affiliated Hospital, School of Medicine,...Westlake Therapeutics招聘中
-
CureVacSyneos Health; Cromos Pharma LLC主动,不招人癌,腺样囊性 | 黑色素瘤(皮肤) | 皮肤鳞状细胞癌 | 癌,头颈部鳞状细胞西班牙, 法国, 奥地利, 德国, 俄罗斯联邦
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Pfizer主动,不招人肾细胞癌 | 胃癌 | 胰腺癌 | 食道癌 | 卵巢癌 | 头颈部鳞状细胞癌 | 胆管癌 | 子宫内膜癌 | 尿路上皮癌 | 肺鳞状细胞癌 | 黑色素瘤癌症美国, 台湾, 大韩民国, 澳大利亚, 斯洛伐克
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.未知
-
The First Affiliated Hospital of Guangdong Pharmaceutical...Guangzhou Anjie Biomedical Technology Co., Ltd.未知
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
Shanghai Jiao Tong University School of Medicine尚未招聘
-
Helios Health Institute GmbHHeart Center Leipzig - University Hospital招聘中
-
Mahmoud Ramadan mohamed Elkazzaz尚未招聘